Cited In for PMID: 29850181

Year	Number of Results
2018	2
2019	2
2020	2
2021	1
2022	3
2023	2
2024	0

1

Biomarkers in malignant pleural mesothelioma: current status and future directions.

Ahmadzada T, Reid G, Kao S. Ahmadzada T, et al. J Thorac Dis. 2018 Apr;10(Suppl 9):S1003-S1007. doi: 10.21037/jtd.2018.04.31. J Thorac Dis. 2018. PMID: 29850181 Free PMC article. No abstract available.

2

Small and Large Extracellular Vesicles Derived from Pleural Mesothelioma Cell Lines Offer Biomarker Potential.

Ahmadzada T, Vijayan A, Vafaee F, Azimi A, Reid G, Clarke S, Kao S, Grau GE, Hosseini-Beheshti E. Ahmadzada T, et al. Cancers (Basel). 2023 Apr 18;15(8):2364. doi: 10.3390/cancers15082364. Cancers (Basel). 2023. PMID: 37190292 Free PMC article.

3

Epigenetic investigation into circulating microRNA 197-3p in sera from patients affected by malignant pleural mesothelioma and workers ex-exposed to asbestos.

Di Mauro G, Frontini F, Torreggiani E, Iaquinta MR, Caselli A, Mazziotta C, Esposito V, Mazzoni E, Libener R, Grosso F, Maconi A, Martini F, Bononi I, Tognon M. Di Mauro G, et al. Sci Rep. 2023 Apr 20;13(1):6501. doi: 10.1038/s41598-023-33116-z. Sci Rep. 2023. PMID: 37081052 Free PMC article.

4

A comprehensive study of alternative splicing in malignant pleural mesothelioma identifies potential therapeutic targets in a new cluster with poor survival.

Shao MM, Qiao X, Chen QY, Yi FS. Shao MM, et al. Thorac Cancer. 2022 Aug;13(16):2318-2330. doi: 10.1111/1759-7714.14564. Epub 2022 Jul 5. Thorac Cancer. 2022. PMID: 35790883 Free PMC article.

5

Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma.

Gao Y, Dai Z, Yang C, Wang D, Guo Z, Mao W, Chen Z. Gao Y, et al. PeerJ. 2022 Jan 4;10:e12568. doi: 10.7717/peerj.12568. eCollection 2022. PeerJ. 2022. PMID: 35036082 Free PMC article.

6

Molecular Pathology of Lung Cancer.

J Saller J, Boyle TA. J Saller J, et al. Cold Spring Harb Perspect Med. 2022 Mar 1;12(3):a037812. doi: 10.1101/cshperspect.a037812. Cold Spring Harb Perspect Med. 2022. PMID: 34751163 Free PMC article. Review.

7

Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population.

Ahmadzada T, Cooper WA, Holmes M, Mahar A, Westman H, Gill AJ, Nordman I, Yip PY, Pal A, Zielinski R, Pavlakis N, Nagrial A, Daneshvar D, Brungs D, Karikios D, Aleksova V, Burn J, Asher R, Grau GE, Hosseini-Beheshti E, Reid G, Clarke S, Kao S. Ahmadzada T, et al. JTO Clin Res Rep. 2020 Jul 16;1(4):100075. doi: 10.1016/j.jtocrr.2020.100075. eCollection 2020 Nov. JTO Clin Res Rep. 2020. PMID: 34589956 Free PMC article.

8

Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma.

Mansour MSI, Seidal T, Mager U, Dobra K, Brunnström H, Dejmek A. Mansour MSI, et al. Cancer Cytopathol. 2021 Jun;129(6):468-478. doi: 10.1002/cncy.22401. Epub 2021 Jan 25. Cancer Cytopathol. 2021. PMID: 33493383 Free PMC article.

9

Genomics and Functional Genomics of Malignant Pleural Mesothelioma.

Cakiroglu E, Senturk S. Cakiroglu E, et al. Int J Mol Sci. 2020 Sep 1;21(17):6342. doi: 10.3390/ijms21176342. Int J Mol Sci. 2020. PMID: 32882916 Free PMC article. Review.

10

Malignant Pleural Effusion and Its Current Management: A Review.

Skok K, Hladnik G, Grm A, Crnjac A. Skok K, et al. Medicina (Kaunas). 2019 Aug 15;55(8):490. doi: 10.3390/medicina55080490. Medicina (Kaunas). 2019. PMID: 31443309 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year